Immunologic monitoring during a phase 2a trial of the GNbAC1 antibody in patients with MS.

Neurol Neuroimmunol Neuroinflamm · 2015 · PMC4547879 · PMID 26380353

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

However, this did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.